ANI PHARMACEUTICALS
ANI Pharmaceuticals is a specialty pharmaceuticals industry that develops, manufactures and markets top-quality prescription pharmaceuticals, made in the U.S.A. ANI manufactures oral solid dose products, as well as liquids and topicals, including narcotics and those that must be manufactured in a fully contained environment due to their potency and/or toxicity. ANI also performs contract manufacturing for other pharmaceutical companies.
ANI PHARMACEUTICALS
Industry:
Biotechnology Health Care Manufacturing Pharmaceutical
Founded:
1996-08-29
Address:
Baudette, Minnesota, United States
Country:
United States
Website Url:
http://www.anipharmaceuticals.com
Total Employee:
101+
Status:
Active
Contact:
(218)634-3500
Email Addresses:
[email protected]
Total Funding:
200 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-03-09 | Novitium Pharma | Novitium Pharma acquired by ANI Pharmaceuticals | 163.5 M USD |
| 2018-08-07 | WellSpring Pharma Services | WellSpring Pharma Services acquired by ANI Pharmaceuticals | 18 M USD |
| 2012-10-04 | BioSante Pharmaceuticals | BioSante Pharmaceuticals acquired by ANI Pharmaceuticals | N/A |
Investors List
Citizens Bank
Citizens Bank investment in Post-IPO Debt - ANI Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-18 | ANI Pharmaceuticals Appoints Meredith W. Cook as SVP, General Counsel and Corporate Secretary |
Official Site Inspections
http://www.anipharmaceuticals.com Semrush global rank: 3.87 M Semrush visits lastest month: 3.33 K
- Host name: elite.olympicwebdesign.com
- IP address: 173.231.203.59
- Location: El Segundo United States
- Latitude: 33.9214
- Longitude: -118.413
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90245
More informations about "ANI Pharmaceuticals"
Board of Directors - ANI Pharmaceuticals, Inc.
Mr. Lalwani is ANI’s President and Chief Executive Officer and a member of ANI’s Board. Prior to joining ANI in September 2020, Mr. Lalwani worked at Cipla Ltd (NSE: CIPLA), a global …See details»
About ANI - ANI Pharmaceuticals
Who We Are. ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, …See details»
2022 Annual Report - ANI Pharmaceuticals, Inc.
Relations at [email protected] INDEPENDENT AUDITORS EisnerAmper LLP One Logan Square 130 North 18th Street, Suite 3000 Philadelphia, PA 19103 Phone: (215) 881 …See details»
Investor FAQs - ANI Pharmaceuticals, Inc.
For more information, please visit our website www.anipharmaceuticals.com. WHEN WAS ANI PHARMACEUTICALS FORMED? On June 19, 2013, pursuant to a merger agreement dated …See details»
ANI Pharmaceuticals, Inc. (ANIP) - Yahoo Finance
See the company profile for ANI Pharmaceuticals, Inc. (ANIP) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
ANI Pharmaceuticals - Crunchbase Company Profile
ANI Pharmaceuticals reported strong growth in Q4 and full-year 2023. The company also secured FDA approval and launched delayed-release naproxen.See details»
ANI Pharmaceuticals - PitchBook
Information on stock, financials, earnings, subsidiaries, investors, and executives for ANI Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
ANI Pharmaceuticals, Inc. | LinkedIn
ANI Pharmaceuticals, Inc. | 18,608 followers on LinkedIn. Serving Patients, Improving Lives | ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving …See details»
ANI Pharmaceuticals, Inc. Information - RocketReach
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and …See details»
ANI Pharmaceuticals, Inc. | LinkedIn
ANI Pharmaceuticals, Inc. | 20,837 followers on LinkedIn. Serving Patients, Improving Lives | ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving …See details»
ANI Pharmaceuticals - Craft
Oct 29, 2024 ANI Pharmaceuticals has 5 employees across 3 locations and $486.82 m in annual revenue in FY 2023. See insights on ANI Pharmaceuticals including office locations, …See details»
Ani Pharmaceuticals - Overview, News & Similar companies
Jun 23, 2024 ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering PRINCETON, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. …See details»
Executive Team - ANI Pharmaceuticals
Executive Team NIKHIL LALWANI, President and Chief Executive Officer Mr. Lalwani is ANI’s President and Chief Executive Officer and a member of ANI’s Board. Prior to joining ANI in …See details»
ANI Pharmaceuticals Announces the Launch of ANI Global Source, …
Nov 1, 2019 BAUDETTE, Minn. /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP), an experienced specialty pharmaceutical and contract development & manufacturing …See details»
ANI Career Site
RECENT NEWS. ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity 2025-01-02See details»
ANI Pharmaceuticals - Medical Information
To report an adverse event related to an ANI product call 1-800-308-6755 or email [email protected] ...See details»
ANI Pharmaceuticals - Board of Directors
He also served as interim Chief Executive Officer of ANI from May 2020 to September 2020. In March 2021, Mr. Walsh was appointed as Chairman and Chief Executive Officer of Alcami, a …See details»
ANI Pharmaceuticals Affirms 2024 Guidance and Provides
7 hours ago ANI Pharmaceuticals, Inc. has reported strong preliminary financial results for 2024 and provided a positive outlook for 2025. The company anticipates total net revenues, …See details»
ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 ...
19 hours ago For more information, visit www.anipharmaceuticals.com. Forward-Looking Statements. To the extent any statements made in this release deal with information that is not …See details»
ANI Pharmaceuticals Shifts Focus From Generics To High-Margin …
Oct 11, 2024 Earlier this year, ANI Pharmaceuticals acquired Alimera Sciences for $5.50 per share in cash and one non-tradable contingent value right (CVR) of up to $0.50 per share …See details»